1. Andersen O, Johansson B, Svennerholm L (1981) Monoamine metabolites in successive samples of spinal fluid. Acta Neurol Scandinav 63:247?254
2. Arthur GR, Boyes RN, Bown D, Lundström J, Lindgren JE, McClure J, Scott DB (1980) Pharmacokinetics of alaproclate, a specific 5-HT uptake inhibitor. Abstract, World conference on clinical pharmacology and therapeutics, London, August 3?9
3. Benton J Sarah, Bowen DM, Allen Shelley I, Haan EA, Davison AN, Neary D, Murphy RP, Snowden Julie S (1982) Alzheimer's disease as a disorder of isodendritic core. Lancet no. 8269 I:456
4. Calil HM, Jostell K-G, Cowdry RW, Potter WZ (1982) Zimelidine and norzimelidine protein binding measured by equilibrium dialysis and cerebrospinal fluid. Clin Pharmacol Ther 31:522?527
5. Carlsson A, Adolfsson R, Aquilonius S-M, Gottfries C-G, Oreland L, Svennerholm L, Winblad B (1980) Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. In: Goldstein M et al. (eds) Ergot compounds and brain function, neuroendocrine and neuropsychiatric aspects. Advances in biochemical psychopharmacology, vol 23. Raven, New York, p 295